Hydrogen Therapy and Glioblastoma: A New Supportive Approach for One of the Most Challenging Brain Cancers
Glioblastoma (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Standard treatments—including surgery, chemotherapy, and radiotherapy—often face major limitations, largely due to the protective role of the blood–brain barrier. This barrier prevents many medications, supplements, and therapeutic molecules from effectively reaching brain tumor tissue. In recent years, hydrogen therapy has gained growing attention because molecular hydrogen is able to cross the blood–brain barrier and act directly within brain tissue. This makes hydrogen a unique candidate as a supportive therapy in glioblastoma management.









